In May 2024, cancer specialists from around the world came together to attend the virtual 2nd China-Europe Anti-Cancer Summit, co-organised by the China Anti-Cancer Association (CACA) and the Latin-American & Caribbean Society of Medical Oncology (SLACOM).

 

Anti-cancer leaders from China and Europe took part in presentations and a panel discussion and exchanged ideas and perspectives on the following:

  • Development of holistic integrative management of cancer in China
  • Status and challenges of cancer prevention and control in Europe
  • A new anti-cancer paradigm by activation of thermogenic adipose tissue

 

 

Organised by CACA and SLACOM


 

Co-organised by eChinaHealth and COR2ED


China-Europe Anti-Cancer Summit 2024: Educational objectives

 

  • Share insights and perspectives on the management and treatment of cancer patients in China and Europe
  • Generate awareness of the latest innovations and progress in cancer research in China and Europe

Programme summary
  • clock Duration 101 MIN
  • clock Language(s) flag
Watch the video now
Share this programme
This educational programme is supported by an Independent Medical Education Grant from BeiGene.
I agree that this educational programme:

Was valuable to me

1/4

Other programmes of interest

Conference update
Oncology 
Oncogene-addicted NSCLC: Highlights from ASCO 2024

The latest non-small cell lung cancer data presented at ASCO

Experts
Prof. Nicolas Girard
  • download Downloadable
    Resources
  • clock 3 MIN
  • calendar Jun 2024

Educational programme supported by an Independent Medical Education grant from Bayer.
Upper lower GI cancer update ASCO 2024 Conference update
Oncology 
Upper and lower GI cancer update from ASCO 2024

GI oncologists review the latest data presented at ASCO 2024

Experts
Dr Samuel J Klempner, Dr Elizabeth Smyth, Prof. Jenny Seligmann, Dr Dominik Modest
  • clock 8 MIN
  • calendar Jun 2024

Educational programme supported by an Independent Medical Education grant from Bayer.
Experts Knowledge Share Video
Oncology Hemato-oncology 
Optimising the management of multiple myeloma in the early relapsed/refractory setting (RRMM)

Medical experts discuss the latest learnings from clinical practice

Experts
Prof. Aurore Perrot, Prof. Hermann Einsele, Assoc. Prof. Karthik Ramasamy, Assoc. Prof. Joshua Richter
  • download Downloadable
    Resources
  • clock 76 MIN
  • calendar Jun 2024

Educational programme supported by an Independent Medical Education grant from Menarini Stemline Oncology.
Conference update

Episode

1

of 4

episode
Oncology 
ASCO 2024 lung cancer highlights

A conference update on lung cancer clinical trial data from ASCO

Experts
Prof. Mark Socinski
  • clock 4 MIN
  • calendar Jun 2024

Conference update

Episode

2

of 4

episode
Oncology 
ASCO 2024 breast cancer highlights

How could the data impact clinical practice?

Experts
Prof. Shaheenah Dawood
  • clock 3 MIN
  • calendar Jun 2024

Conference update

Episode

3

of 4

episode
Oncology 
ASCO 2024 HCC highlights

How could the latest clinical trial data impact the management of hepatocellular carcinoma?

Experts
Prof. Dr Peter R. Galle
  • clock 1 MIN
  • calendar Jun 2024